Sequencing methods and compositions for prenatal diagnoses
AssigneeVerinata Health, Inc.
InventorsRichard P. Rava, Manjula Chinnappa, David A. Comstock, Gabrielle Heilek, Brian Kent Rhees
Life of this patent
Estimating the term…
Abstract
The invention provides methods for determining aneuploidy and/or fetal fraction in maternal samples comprising fetal and maternal ctDNA by massively parallel sequencing. The method comprises a novel protocol for preparing sequencing libraries that unexpectedly improves the quality of library DNA while expediting the process of analysis of samples for prenatal diagnoses.
Claims2
A method for determining a fetal chromosomal aneuploidy in a maternal sample comprising a mixture of fetal and maternal nucleic acids molecules, said method comprising:
- (a) preparing a sequencing library from said mixture of fetal and maternal nucleic acid molecules;
- wherein preparing said library comprises the consecutive steps of end-repairing, dA-tailing and adaptor ligating said nucleic acids;
- (b) sequencing at least a portion of said nucleic acid molecules, thereby obtaining sequence information for a plurality of fetal and maternal nucleic acid molecules of a maternal sample;
- (c) using the sequence information to obtain a chromosome dose for an aneuploid chromosome;
- and
- (d) comparing said chromosome dose to at least one threshold value, and thereby identifying the presence or absence of fetal aneuploidy
2-43. (canceled)
Dependencies are inferred from the claim text.